Does Rallies show Form 4 insider transactions for IRTC?

Yes. Rallies tracks IRTC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is IRTC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IRTC. It does not provide personalized investment advice.

IRTC (iRhythm Holdings, Inc. Common Stock) Stock Analysis - Insider Trades

iRhythm Holdings, Inc. Common Stock (IRTC) is a publicly traded Healthcare sector company. As of May 21, 2026, IRTC trades at $117.02 with a market cap of $3.65B and a P/E ratio of -83.62. IRTC moved +2.80% today. Year to date, IRTC is -36.55%; over the trailing twelve months it is -17.14%. Its 52-week range spans $55.92 to $212.00. Analyst consensus is strong buy with an average price target of $184.00. Rallies surfaces IRTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading IRTC stock inside the company?

Recent IRTC insider activity includes TALWALKAR ABHIJIT Y bought 5.31K, TALWALKAR ABHIJIT Y sold 940, TALWALKAR ABHIJIT Y sold 642, TALWALKAR ABHIJIT Y sold 2.29K, and TALWALKAR ABHIJIT Y sold 1.15K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

IRTC Key Metrics

Key financial metrics for IRTC
Metric	Value
Price	$117.02
Market Cap	$3.65B
P/E Ratio	-83.62
EPS	$-1.39
Dividend Yield	0.00%
52-Week High	$212.00
52-Week Low	$55.92
Volume	1
Avg Volume	0
Revenue (TTM)	$747.14M
Net Income	$-44.55M
Gross Margin	70.57%

Recent IRTC Insider Trades

TALWALKAR ABHIJIT Y bought 5.31K (~$56.89K) on May 11, 2026.
TALWALKAR ABHIJIT Y sold 940 (~$109.09K) on May 11, 2026.
TALWALKAR ABHIJIT Y sold 642 (~$75.10K) on May 11, 2026.
TALWALKAR ABHIJIT Y sold 2.29K (~$270.61K) on May 11, 2026.
TALWALKAR ABHIJIT Y sold 1.15K (~$136.67K) on May 11, 2026.

Latest IRTC News

iRhythm Q1 Revenue Jumps 25.7% to $199.4M; Full-Year Guidance Upgraded — Apr 30, 2026
iRhythm Data Shows 26% Post-Ablation AF Recurrences, 60% Pregnancy Arrhythmias Detected After 48 Hours — Apr 27, 2026
iRhythm launches Academy, shows 48% arrhythmia in CKD and 2.8x AF risk — Mar 30, 2026
iRhythm Appoints UnitedHealth Enterprise Strategy EVP Jason Patten to Board — Mar 12, 2026
iRhythm Reports Q4 Revenue Up 27.1% to $208.9M, First GAAP Profit — Mar 2, 2026

IRTC Analyst Consensus

13 analysts cover IRTC: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $184.00.

Common questions about IRTC

Who is trading IRTC stock inside the company?: Recent IRTC insider activity includes TALWALKAR ABHIJIT Y bought 5.31K, TALWALKAR ABHIJIT Y sold 940, TALWALKAR ABHIJIT Y sold 642, TALWALKAR ABHIJIT Y sold 2.29K, and TALWALKAR ABHIJIT Y sold 1.15K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for IRTC?: Yes. Rallies tracks IRTC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is IRTC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IRTC. It does not provide personalized investment advice.